EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728211003716442
Reference116 articles.
1. Recent Advances in Head and Neck Cancer
2. Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment
3. Global Cancer Statistics, 2002
4. Cell Signaling by Receptor Tyrosine Kinases
5. Nuclear localization of EGF receptor and its potential new role as a transcription factor
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Network pharmacology: an efficient but underutilized approach in oral, head and neck cancer therapy—a review;Frontiers in Pharmacology;2024-07-05
2. Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer;International Journal of Molecular Sciences;2023-07-20
3. Molecular Biology of Head and Neck Cancer;Airway diseases;2023
4. Current trends and future prospects of molecular targeted therapy in head and neck squamous carcinoma;Treatment Landscape of Targeted Therapies in Oncology;2023
5. 89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma;Clinical Cancer Research;2022-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3